Stanford Medcast Episode 94: Emerging Technology Mini-Series - Nanotechnology in Pediatric Cancer Imaging

In this episode Dr. Adewuya is joined by Dr. Heike Daldrup-Link, a Professor of Radiology at Stanford University. Our conversation explores the fascinating intersection of nanotechnology and clinical medicine, particularly its transformative role in medical imaging and its significance for pediatric oncology. We discuss how nanoparticles function within the body for imaging purposes, highlighting their advantages over traditional imaging agents. Our discussion covers the advancements in precision medicine in cancer imaging, including the reduced side effects associated with safer imaging modalities. Additionally, we will examine the ethical considerations of utilizing nanoparticles in children, explore ongoing clinical trials, and discuss potential long-term health effects on pediatric patients.

To Claim Credit for listening to this episode:
1. Go to 'Begin' and click on 'Claim CE.'
2. Follow prompts to complete an evaluation.
3. Credit hours will be reflected on your transcript, or you may download your certificate.

1. Review novel pediatric molecular imaging techniques to use in the care of pediatric patients.
2. Consider the potential long term health effects of nanoparticles in pediatric patients.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodationsplease contact the CME Office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
1.Kiru, L., Zlitni, A., Tousley, A. M., Dalton, G. N., Wu, W., Lafortune, F., Liu, A., Cunanan, K. M., Nejadnik, H., Sulchek, T., Moseley, M. E., Majzner, R. G., & Daldrup-Link, H. E. (2022). In vivo imaging of nanoparticle-labeled Car T cells. Proceedings of the National Academy of Sciences, 119(6). https://doi.org/10.1073/pnas.2102363119
2.Omidian, H., & Mfoafo, K. (2023, May 24). Exploring the potential of nanotechnology in pediatric healthcare: Advances, challenges, and future directions. Pharmaceutics. https://pmc.ncbi.nlm.nih.gov/articles/PMC10303369/
3.Yang, S., Wallach, M., Krishna, A., Kurmasheva, R., & Sridhar, S. (2021, April 1). Recent developments in nanomedicine for pediatric cancer. Journal of clinical medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC8036287/

For activity related questions, please contact
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Ruth Adewuya, MD
Managing Director
Stanford University

Course Director, Reviewer

Nothing to disclose

Heike Daldrup-Link, MD
Stanford University

Faculty

Grant or research support-MegaPro Biomedical Co Ltd

Lydia Wang
Medcast Intern
Stanford

Planner

Nothing to disclose